Cancer therapy recommendation platform, preclinical CRO

Certis Oncology Solutions leverages advanced technologies to enhance cancer research and drug development. One of their key offerings is CertisAI™, which utilizes artificial intelligence to create sophisticated cancer models. These models are designed to support drug developers in understanding cancer biology and evaluating therapeutic options. The company also specializes in custom model development, providing tailored solutions that include in vitro and ex vivo pharmacology, as well as in vivo pharmacology. Their imaging and endpoint analysis capabilities further enable precise assessment of treatment efficacy, particularly in the context of immuno-oncology.

In addition to their modeling technologies, Certis Oncology Solutions emphasizes the importance of clinical research and patient education. They provide resources such as a patient education library and cancer facts to empower both patients and oncologists. Their YourPDX® platform facilitates the ordering of patient-derived xenografts (PDX), which are crucial for translating research findings into clinical applications. Overall, Certis Oncology Solutions is committed to advancing cancer treatment through innovative technologies and comprehensive support for drug developers and healthcare professionals.

United States

Certis Oncology is a life science technology company committed to realizing the promise of precision oncology. Certis was founded in 2016 with a singular purpose: to bring certainty to the fight against cancer. Their science delivers clinically relevant, predictive data and they are located in the heart of San Diego's Life Sciences center, Sorrento Valley.

Certis Oncology Solutions

Company Details